期刊
ANTIBIOTICS-BASEL
卷 6, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/antibiotics6010003
关键词
antibiotic resistant pulmonary tuberculosis; thioridazine; in vitro activity; ex vivo activity; in vivo activity (murine model and human trails); the non-killing macrophage; enhancement of intracellular killing of Mtb by thioridazine; mechanism of actions of thioridazine
资金
- FCT Fundacao para a Ciencia e a Tecnologia (FCT) [UID/Multi/04413/2013]
- FCT
- Gulbenkian Foundation
This review presents the evidence that supports the use of thioridazine (TZ) for the therapy of a pulmonary tuberculosis infection regardless of its antibiotic resistance status. The evidence consists of in vitro and ex vivo assays that demonstrate the activity of TZ against all encountered Mycobacterium tuberculosis (Mtb) regardless of its antibiotic resistance phenotype, as well as in vivo as a therapy for mice infected with multi-drug resistant strains of Mtb, or for human subjects infected with extensively drug resistant (XDR) Mtb. The mechanisms of action by which TZ brings about successful therapeutic outcomes are presented in detail.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据